News|Articles|February 24, 2026

Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU

Fact checked by: Alex Biese

Oncologists highlight key 2026 ASCO GU studies in bladder, prostate, kidney and testicular cancers that could reshape treatment and personalize care.

As the cancer community gets ready for the 2026 ASCO Genitourinary (GU) Cancers Symposium, we at CURE are focusing on what the latest research could mean for people living with bladder, prostate, kidney, testicular and other genitourinary cancers. This annual meeting often brings news about new treatments, better ways to use current therapies and ways that may help doctors personalize care.